HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tran Thi Hien Selected Research

nectandrin-B

4/2014Nectandrin B suppresses the expression of adhesion molecules in endothelial cells: Role of AMP-activated protein kinase activation.
2/2013Protective effect of nectandrin B, a potent AMPK activator on neointima formation: inhibition of Pin1 expression through AMPK activation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tran Thi Hien Research Topics

Disease

7Neoplasms (Cancer)
11/2020 - 07/2010
4Breast Neoplasms (Breast Cancer)
09/2022 - 07/2010
3Atherosclerosis
04/2014 - 09/2010
2Arthritis (Polyarthritis)
02/2018 - 03/2015
2Hypertension (High Blood Pressure)
01/2018 - 07/2014
2Vascular System Injuries
01/2018 - 06/2015
2Vascular Diseases (Vascular Disease)
06/2017 - 06/2015
2Cardiovascular Diseases (Cardiovascular Disease)
06/2017 - 11/2011
2Neointima
02/2013 - 06/2010
1Urinary Bladder Neoplasms (Bladder Cancer)
11/2020
1Rheumatoid Arthritis
01/2019
1Bronchitis
02/2018
1Menstruation Disturbances
02/2018
1Carbuncle
02/2018
1Aortic Aneurysm (Aneurysm, Aortic)
06/2017
1Vascular Remodeling
01/2017
1Pulmonary Arterial Hypertension
01/2017
1Hyperglycemia
02/2016
1Edema (Dropsy)
03/2015
1Pain (Aches)
03/2015
1Hyperuricemia
07/2014
1Insulin Resistance
07/2014
1Liver Cirrhosis (Hepatic Cirrhosis)
06/2014
1Hyperplasia
02/2013
1Infections
06/2010

Drug/Important Bio-Agent (IBA)

2Peptidylprolyl Isomerase (Prolyl Isomerase)IBA
06/2014 - 06/2011
2nectandrin-BIBA
04/2014 - 02/2013
2amurensin GIBA
12/2012 - 11/2010
2puerarinIBA
11/2011 - 07/2010
2Doxorubicin (Adriamycin)FDA LinkGeneric
11/2010 - 07/2010
1formosanin CIBA
09/2022
1Therapeutic UsesIBA
11/2020
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2020
1salicylhydroxamic acid (SHAM)IBA
11/2020
1Cyclin D1IBA
11/2020
1Tumor Biomarkers (Tumor Markers)IBA
11/2020
11-nitrosoindole-3-acetonitrileIBA
01/2019
1Angiotensin IIIBA
01/2018
1MicroRNAs (MicroRNA)IBA
06/2017
1Serotonin (5 Hydroxytryptamine)IBA
01/2017
1rho-Associated KinasesIBA
02/2016
1Glucose (Dextrose)FDA LinkGeneric
02/2016
1DystrophinIBA
06/2015
1CarrageenanIBA
03/2015
1Collagen Type II (Type II Collagen)IBA
03/2015
1allantoxanamideIBA
07/2014
1Nitric Oxide (Nitrogen Monoxide)FDA Link
07/2014
1Insulin (Novolin)FDA Link
07/2014
1Urate Oxidase (Uricase)IBA
07/2014
1Uric Acid (Urate)IBA
07/2014
1Dimethylnitrosamine (Nitrosodimethylamine)IBA
06/2014
1Proteins (Proteins, Gene)FDA Link
07/2013
1TamoxifenFDA LinkGeneric
07/2013
1ATP-Binding Cassette Sub-Family B Member 4IBA
07/2013
1Multidrug Resistance-Associated Protein 2IBA
07/2013
1Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
12/2012
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
03/2011
1Sirtuin 1IBA
11/2010
1Antineoplastic Agents (Antineoplastics)IBA
11/2010
1SaponinsIBA
09/2010
1ginsenoside Rg3IBA
09/2010
1CytokinesIBA
09/2010
1ElementsIBA
07/2010
1AMP-Activated Protein KinasesIBA
07/2010
1NF-kappa B (NF-kB)IBA
07/2010
1Heme Oxygenase-1IBA
06/2010
1Green Fluorescent ProteinsIBA
06/2010
1AntioxidantsIBA
06/2010

Therapy/Procedure

2Drug Therapy (Chemotherapy)
11/2010 - 07/2010
1Therapeutics
11/2020
1Intravesical Administration
11/2020
1Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2019
1Traditional Medicine (Folk Remedies)
02/2018